NIH awards $3.96 million to develop combination therapies for superbugs
Medicamente
University of Houston Nov 15 2024 Gram-negative bacteria pose a serious threat to global health because they can resist multiple antibiotics, making infections difficult to treat, according to the National Institutes of Health. In response, the NIH has awarded $3.96 million to Vincent Tam, professor of Pharmacy Practice and Translational Research at the UH College of Pharmacy, to outsmart these superbugs by designing more effective combination therapies that can overcome their defenses. Tam
din zilele anterioare